Health & Life Sciences Opening Up Mortality Data for Health Research Comprehensive and reliable mortality data will enable more effective response to rapidly evolving public health challenges.
Health & Life Sciences Delivering Healthcare Services to the American Home Increasing the share of health services provided directly to patient homes is a significant opportunity to improve healthcare in the U.S.
Health & Life Sciences A Federal Adaptive, On-Demand Pharmaceutical Manufacturing Initiative An investment of $5 billion over five years will improve U.S. pharmaceutical manufacturing infrastructure.
Health & Life Sciences Rethinking Payment for Prevention in Healthcare The government should provide incentives to healthcare providers that scale up and reduce costs of delivering preventive interventions.
Health & Life Sciences Elevating Patients as Partners in Management of Their Health Data and Tissue Samples The next administration should empower patients as partners in managing of their health data and tissue samples.
Health & Life Sciences Providing High-Quality Telehealth Care for Veterans The Federal Government should build critical technology infrastructure that will facilitate expansion and use of telehealth for veterans.
Health & Life Sciences An Evidence-based Approach to Controlling Drug Costs The next administration should control drug costs through an evidence-based approach to optimizing drug dosing and improving outcomes.
Health & Life Sciences Innovation & Economic Competitiveness Advancing Economic, Health, and Racial Equity by Increasing the Use of Evidence and Data The next administration should ensure equitable recovery and economic mobility by promoting evidence-based decision-making across agencies.
Health & Life Sciences Innovation & Economic Competitiveness A National Bioeconomy Manufacturing and Innovation Initiative A National Bioeconomy Manufacturing and Innovation Initiative would combat COVID-19, foster economic recovery, and address climate change.
